Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients

Distinguishing between patients with early stage, screen detected prostate cancer who must be treated from those that can be safely watched has become a major issue in prostate cancer care. Identification of molecular subtypes of prostate cancer has opened the opportunity for testing whether biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, James D., Wei, Wei, Hawley, Sarah, Auman, Heidi, Newcomb, Lisa, Boyer, Hilary, Fazli, Ladan, Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A., Carroll, Peter R., Gleave, Martin, Lance, Raymond, Lin, Daniel W., Nelson, Peter S., Thompson, Ian M., True, Lawrence D., Feng, Ziding, McKenney, Jesse K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501723/
https://www.ncbi.nlm.nih.gov/pubmed/26172920
http://dx.doi.org/10.1371/journal.pone.0132343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501723/
https://www.ncbi.nlm.nih.gov/pubmed/26172920
http://dx.doi.org/10.1371/journal.pone.0132343

Ejemplares similares